Diabetes

Diabetes mellitus - often referred to simply as diabetes - is a condition in which the body either does not produce any insulin (Type 1) or not enough insulin. Insulin is a hormone produced in the pancreas to overcome the underlying insulin resistance of the cells in the body (Type 2). Insulin enables glucose (sugar) to enter the cells in order to be stored as glycogen or oxidized for energy. These defects cause glucose to accumulate in the blood, inevitably leading to serious complications. The positive effects of moderate wine and other alcoholic beverage consumption are only relevant for individuals with type-2 diabetes.

 

Type 2 Diabetes

 

The underlying defect is insulin resistance due to obesity and lack of exercise. Insulin resistance means that the cells do not respond to the insulin signal. In return, the pancreas tries to overcome this resistance by increasing the insulin output which enables the glucose to enter the cells. Once the beta-cells cannot compensate the high demand of insulin for proper function, the glucose will remain in the blood leading to an increased blood sugar level. Approximately 90% of all cases of diabetes worldwide are type 2.

 

In 2010, the International Diabetes Federation estimated the global prevalence of diabetes mellitus at 6.6% in adults. Type-2 diabetes is now one of the most common non-communicable diseases in the world and a major cause of premature illness and death in most countries. To prevent diabetic complications and premature death, patients are recommended to adopt a healthy lifestyle.  

 

Evidence from randomized-controlled intervention studies as well as from population studies have demonstrated that light to moderate consumption of alcoholic beverages will improve insulin sensitivity in insulin resistant people. Accordingly, large prospective studies have shown a reduced risk for developing the metabolic syndrome (MS, name for a group of risk factors that raise the risk for heart disease, stroke and diabetes. A metabolic syndrome exists when at least 3 of the following risk factors are present: overweight, high triglyceride level, elevated plasma glucose level,  low HDL cholesterol level and high blood pressure) . A moderate intake of  wine as well as other alcoholic beverages exerts a beneficial effect on MS. In addition, large population studies suggest that light to moderate consumption of alcoholic beverages is associated with a lower diabetic risk than abstaining or heavy drinking, independently of the type of alcoholic beverage consumed. Meta-analyses reported a J-shaped relationship for men and women with a reduced risk for a moderate intake of alcoholic beverages and an increased risk for more than 50-60 g/d. With regards to wine and diabetes, most studies found  beneficial effects. But not only the risk of developing type 2 diabetes is decreased with moderate drinking; it may also reduce CHD and CVD mortality in diabetics as well as potential cardiac complications relating to diabetes. This is especially important considering that coronary heart disease (CHD) is the leading cause of death among individuals with type-2 diabetes, who also have a 4-fold increased risk of having a heart attack or stroke. Research indicates that this risk decreases considerably when they consume wine moderately with meals.

 

Considering the world-wide epidemic of type 2 diabetes which is expected to rise even further and is associated with major health care costs, preventing diabetes is a major public health issue. It seems that drinking wine in moderation could  help reduce type 2 diabetes and thereby contribute to public health.


The above summary provides an overview of the topic, for more details and specific questions, please refer to the articles in the database.

 

 

 

 

Health benefits of moderate wine consumption have been studied during the past decades, first in observational studies and more recently, in experimental settings and randomized controlled studies. Suggested biological pathways include antioxidant, lipid regulating, and anti-inflammatory effects. Both the alcoholic and polyphenolic components of wine are believed to contribute to these beneficial effects. Although several of these studies demonstrated protective associations between moderate drinking and cardiovascular disease, atherosclerosis, hypertension, certain types of cancer, type 2 diabetes, neurological disorders, and the metabolic syndrome, no conclusive recommendations exist regarding moderate wine consumption. Yet, it is suggested that the physician and patient should discuss alcohol use. In the CASCADE (CArdiovaSCulAr Diabetes & Ethanol) trial, 224 abstainers with type 2 diabetes were randomized to…
BACKGROUND AND AIMS: We prospectively assessed the association between a healthy lifestyle score (HLS) and the risk of type 2 diabetes mellitus (T2DM) in a Mediterranean cohort. METHODS AND RESULTS: We followed up 11,005 participants initially free of diabetes diagnosis in the "Seguimiento Universidad de Navarra" (SUN) cohort. We evaluated the influence of lifestyle-related factors based on a score previously related to a lower risk of cardiovascular disease. Only one incident case of T2DM was found among those with a baseline BMI 22 kg/m(2). We measured the baseline adherence of a HLS that included: never smoking, physical activity, Mediterranean diet adherence, moderate alcohol consumption, avoidance of binge drinking, low television exposure, taking a short nap, spending time with friends and…
The ultimate goal of diabetes management is to minimize complications and maintain quality of life in the context of comprehensive cardiovascular risk management and patient-centered care. This includes lifestyle management and diabetes self-management education and support. In contrast to current pharmacological guidelines, which are patient-centered and evidence based, lifestyle guidelines still carry potential for improvement. Despite current best evidence from prospective controlled trials showing, that moderate wine consumption is associated with survival benefi t, reduced risk of cardiovascular endpoints in both subjects with and without diabetes as well as reduced diabetes incidence in the context of the mediterranean diet, translation into clinical practice is unsatisfactory. Patients with diabetes and prediabetes need balanced and accurate information so they can make informed…
BACKGROUND: This study aims to examine the association between alcohol consumption and the risk of pre- or type 2 diabetes mellitus (T2DM) by alcohol-induced flushing response in Korean male adults, particularly based on their body mass index (BMI). METHODS: This study selected 1,030 (158 non-drinkers, 364 flushers, and 508 non-flushers) male adults who had medical checkups. A logistic regression analysis was used to compare the association between alcohol consumption and the risk of pre- or T2DM. RESULTS: In both the normal-weight group (BMI /=23 kg/m(2) and 4 and 8 drinks: 2.42, 1.11-5.27). However, obese non-flushers had only a significant higher risk of pre- or T2DM when consuming more than 8 drinks of alcohol per week than the non-drinkers (2.72, 1.39-5.30).…
We aimed to elucidate the effect of chronic alcohol consumption on fatty liver. We assessed the consumption of alcohol in 2429 Japanese males (mean age: 54.2 +/- 9 years); they were classified according to average consumption into non-drinkers (ND), light drinkers (LD), moderate drinkers (MD), and heavy drinkers (HD). The prevalence of fatty liver was the lowest in the MD and highest in the ND group (p < 0.001), while obesity was not significantly different among the groups (p = 0.133). Elevated levels of alanine aminotransferase (ALT) were the lowest in the MD group (p = 0.011) along with resistance to insulin (homeostasis model assessment-insulin resistance (HOMA-IR)), which was highest in the ND group (p = 0.001). Chronic consumption of…
Page 5 of 28

Contact us

We love your feedback. Get in touch with us.

  • Tel: +32 (0)2 230 99 70
  • Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Disclaimer

The authors have taken reasonable care in ensuring the accuracy of the information herein at the time of publication and are not responsible for any errors or omissions. Read more on our disclaimer and Privacy Policy.